References
- Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Heptology 2001;33:1353–7.
- Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlamyr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989;209:88–9.
- O´Grady JG, Polosn RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 patients. Ann Surg 1988;207:373–9.
- Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999;10(Suppl 4):308–11.
- Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610–15.
- Leidenius M, Höckerstedt K, Broome U, Ericzon B-G, Friman S, Olausson M, Schrumpf E. Heptobiliary carcinoma in primary sclerosing cholangitis: a case control study. J Hepatol 2001;34:792–8.
- Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002;37:1205–11.
- Bergquist A, Ekblom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321–7.
- Brandsaeter B, Isoniemi H, Broomé U, Olausson M, Bäckman L, Hansen B, Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004;40:815–22.
- De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG, Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinom. Liver Transpl 2000;6:309–16.
- Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, Transplantation for Hilar Cholangiocarcinoma. Liver Transpl 2004;10:65–8.
- Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Liver transplantation with neoadjuvant chemoradiation is more effective than resection for Hilar Cholangiocarcinoma. Ann Surg 2005;242:451–8.
- International Union Against Cancer (UICC): TNM Classification of malignant tumours. 6th ed. 2002. pp 81–89.
- Robles R, Figueras J, Turrion VS, Margarit C, Moya A, Varo E, Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma. Ann Surg 2004;239:265–71.
- Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, Liver Transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 2001;7:1223–33.
- Ghali P, Marotta PJ, Yoshida EM, Bain VG, Marleau D, Peltekian K, Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 2005;11:1412–16.
- Lang H, Sotiropoulos GC, Sgourakis G, Schmitz KJ, Paul A, Hilgard P, Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 2009;208:218–28.
- Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997;185:429–36.
- Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The Value of Serum CA 19-9 in Predicting Cholangiocarinomas in Patients with Primary Sclerosing Cholangitis. Dig Dis Sci 2005;50:1734–40.
- Björnsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999;19:501–8.
- Hultcrantz R, Olsson R, Danielsson A, Järnerot G, Lööf L, Ryden BO, A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999;30:669–73.
- Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 2006;45:568–74.
- Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B Jr, McCashland T, Radiohemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002;2:774–9.
- McCashland T, Watt K, Lyden E, Adams L, Carlton M, Smith AD, Retransplantation for hepatitis C: results of a U.S multicenter retransplant study. Liver Transpl 2007;13:1246–53.